Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

N-[[4'-[(2-Ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridine-3-yl)methyl][1,1'-biphenyl]-2-yl]sul-fonyl]-4-[11C]methoxybenzamide.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2006 May 17 [updated 2012 Mar 14].

2.

2-Butyl-5-[11C]methoxymethyl-6-(1-oxopyridin-2-yl)-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-3H-imidazo[4,5-b]pyridine.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2006 May 12 [updated 2012 Mar 21].

3.

Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtype.

Wong PC, Quan ML, Saye JM, Bernard R, Crain EJ Jr, McCall DE, Watson CA, Zaspel AM, Smith RD, Wexler RR, et al.

J Cardiovasc Pharmacol. 1995 Sep;26(3):354-62.

PMID:
8583775
4.
5.

Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.

Haddad G, Amiri F, Garcia R.

Regul Pept. 1997 Jan 29;68(2):111-7.

PMID:
9110382
6.

Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindoles.

Dhanoa DS, Bagley SW, Chang RS, Lotti VJ, Chen TB, Kivlighn SD, Zingaro GJ, Siegl PK, Patchett AA, Greenlee WJ.

J Med Chem. 1993 Dec 24;36(26):4230-8.

PMID:
8277505
7.

Development of [11C]L-159,884: a radiolabelled, nonpeptide angiotensin II antagonist that is useful for angiotensin II, AT1 receptor imaging.

Hamill TG, Burns HD, Dannals RF, Mathews WB, Musachio JL, Ravert HT, Naylor EM.

Appl Radiat Isot. 1996 Feb;47(2):211-8.

PMID:
8852629
8.

In vitro pharmacology of a novel non-peptide angiotensin II-receptor antagonist, E4177.

Okunishi H, Song K, Oka Y, Kobayashi T, Kawamoto T, Ishihara H, Mori N, Miyazaki M.

Jpn J Pharmacol. 1993 Jul;62(3):239-44.

9.

Angiotensin II receptor subtypes and contractile responses in portal vein smooth muscle.

Pelet C, Mironneau C, Rakotoarisoa L, Neuilly G.

Eur J Pharmacol. 1995 Jun 6;279(1):15-24.

PMID:
7556378
10.
11.

Distribution and functional significance of angiotensin-II AT1- and AT2-receptor subtypes in the rat adrenal gland.

Belloni AS, Andreis PG, Macchi V, Gottardo G, Malendowicz LK, Nussdorfer GG.

Endocr Res. 1998 Feb;24(1):1-15.

PMID:
9553751
12.

Pharmacological profiles of a novel non-peptide angiotensin II type I receptor antagonist HR720 in vitro and in vivo.

Jin D, Song K, Oka Y, Takai S, Shiota N, Miyazaki M.

Jpn J Pharmacol. 1997 Nov;75(3):259-66.

13.
14.

Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR.

Touyz RM, Endemann D, He G, Li JS, Schiffrin EL.

Hypertension. 1999 Jan;33(1 Pt 2):366-72.

15.

Biochemical properties of the ovarian granulosa cell type 2-angiotensin II receptor.

Pucell AG, Hodges JC, Sen I, Bumpus FM, Husain A.

Endocrinology. 1991 Apr;128(4):1947-59.

PMID:
1848506
16.

Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.

Ruan X, Wagner C, Chatziantoniou C, Kurtz A, Arendshorst WJ.

J Clin Invest. 1997 Mar 1;99(5):1072-81.

17.

Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors.

Wolf G, Wenzel U, Burns KD, Harris RC, Stahl RA, Thaiss F.

Kidney Int. 2002 Jun;61(6):1986-95.

18.

Modulation of the AT2 subtype receptor gene activation and expression by the AT1 receptor in endothelial cells.

De Paolis P, Porcellini A, Gigante B, Giliberti R, Lombardi A, Savoia C, Rubattu S, Volpe M.

J Hypertens. 1999 Dec;17(12 Pt 2):1873-7.

PMID:
10703883
19.

Supplemental Content

Support Center